查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1888694

经导管心臟瓣膜市场规模、份额和趋势分析报告：按应用、技术、地区和细分市场预测（2025-2033 年）

Transcatheter Heart Valve Market Size, Share & Trends Analysis Report By Application, By Technology, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

经导管心臟瓣膜市场摘要

2024年全球经导管心臟瓣膜市场规模估计为54.9亿美元，预计到2033年将达到212.4亿美元。

预计 2025 年至 2033 年的复合年增长率将达到 16.49%。瓣膜性心臟病的盛行率不断上升，尤其是在老化社会中，这推动了对经导管心臟瓣膜 (THV) 治疗的需求，包括经导管主动脉瓣置换术术 (TAVR)，用于治疗主动脉瓣狭窄和二尖瓣逆流等疾病。

推动经导管心臟瓣膜产业发展的关键因素包括经导管心臟瓣膜设计的不断改进、影像技术和输送系统的进步，以及人们对微创手术日益增长的偏好。与传统的开胸手术相比，微创手术有望带来更快的恢復时间、更少的併发症和更低的医疗成本。

2024年9月，美国疾病管制与预防中心（CDC）报告称，75%的美国美国对瓣膜性心臟病的了解有限。这种认知不足对高风险族群的影响尤其显着，包括65岁以上的老年人。在美国，每年有超过500万人被诊断出患有瓣膜性心臟病，该疾病每年导致超过2.5万人死亡。

心臟瓣膜疾病的盛行率不断上升，尤其是在老化人口中，是经导管心臟瓣膜置换术（THV）需求的主要驱动因素。随着主动脉瓣狭窄和二尖瓣逆流等疾病的日益常见，对THV等先进治疗方案的需求也日益增长。 2024年9月，美国疾病管制与预防中心（CDC）报告称，75%的美国成年人对心臟瓣膜疾病的了解有限。这种认知不足的情况在高风险族群中尤为突出，例如65岁及以上的老年人。在美国，每年有超过500万人被诊断出患有心臟瓣膜疾病，超过2.5万人死于该疾病。

经导管主动脉瓣膜（THV）设计的持续改进，特别是瓣膜耐久性的提升、植入操作的简单性以及患者预后的改善，是推动THV发展的关键因素。影像技术的进步和瓣膜输送系统的改进也显着提高了手术成功率，并扩大了THV手术的适用患者群体。 2024年8月，波士顿科学公司宣布其ACURATE Prime主动脉瓣膜系统获得CE认证。这款先进的经导管主动脉瓣膜置换系统采用新型瓣膜尺寸，以适应体型较大的患者，适用于低危险群、中度风险和高风险重度主动脉瓣狭窄患者。该系统采用自膨胀式设计和改进的释放机制，提高了瓣膜定位的精准度，从而改善患者的整体预后。

目录

第一章调查方法和范围

第二章执行摘要

3. 经导管心臟瓣膜市场变数、趋势和范围

  • 市场谱系展望
    • 母市场展望
    • 相关及辅助市场展望
  • 市场动态
  • 经导管心臟瓣膜市场分析工具
    • 产业分析 - 波特五力
    • PESTEL 分析

第四章 经导管心臟瓣膜市场：按应用分類的估算和趋势分析

  • 定义和范围
  • 按应用领域分類的市场份额分析（2024 年和 2033 年）
  • 经导管主动脉瓣膜
  • 经导管肺动脉瓣膜
  • 经导管二尖瓣

第五章 经导管心臟瓣膜市场：依技术分類的估算与趋势分析

  • 定义和范围
  • 按应用领域分類的市场份额分析（2024 年和 2033 年）
  • 球囊扩张型经导管瓣膜
  • 自膨式经导管瓣膜

第六章 经导管心臟瓣膜市场：区域估算与趋势分析

  • 区域仪錶板
  • 市场规模、预测与趋势分析（2021-2033）
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第七章 竞争情势

  • 公司/竞争对手分类
  • 供应商概况
    • 主要企业市占率分析，2024 年
    • Medtronic
    • Abbott
    • Braile Biomedica
    • Meril Life Sciences Pvt. Ltd., Inc.
    • Edwards Lifesciences Corporation
    • MicroPort Scientific Corporation
    • Venus Medtech（Hangzhou）Inc.
    • JenaValve
    • Biosensors International Group, Ltd
    • HLT Medical（Bracco）
Product Code: GVR-1-68038-096-5

Transcatheter Heart Valve Market Summary

The global transcatheter heart valve market size was estimated at USD 5.49 billion in 2024 and projected to reach USD 21.24 billion by 2033, growing at a CAGR of 16.49% from 2025 to 2033. The rising prevalence of heart valve diseases, particularly in the aging population, is driving the demand for transcatheter heart valve (THV) procedures, such as TAVR, especially for conditions such as aortic stenosis and mitral regurgitation.

Key factors propelling the growth of the transcatheter heart valve industry include continuous improvements in THV design, advancements in imaging and delivery systems, and the increasing preference for minimally invasive surgeries, which offer shorter recovery times, reduced complications, and lower healthcare costs compared to traditional open-heart surgery.

In September 2024, the CDC reported that 75% of adults in the U.S. have limited knowledge about heart valve disease. This lack of awareness extends to high-risk groups, particularly individuals aged 65 and older. Each year, over 5 million people in the U.S. receive a diagnosis of heart valve disease, contributing to more than 25,000 fatalities attributed to this condition annually.

The growing prevalence of heart valve diseases, particularly in the aging population, significantly drives the demand for transcatheter heart valve (THV) procedures. Conditions such as aortic stenosis and mitral regurgitation are becoming more common, necessitating advanced treatment solutions such as THVs. In September 2024, the CDC reported that 75% of adults in the U.S. have limited knowledge about heart valve disease. This lack of awareness extends to high-risk groups, particularly individuals aged 65 and older. Each year, over 5 million people in the U.S. receive a diagnosis of heart valve disease, contributing to more than 25,000 fatalities attributed to this condition annually.

Continuous improvements in THV design, including enhanced valve durability, ease of implantation, and improved patient outcomes, are crucial drivers. Advancements in imaging techniques and valve delivery systems have also significantly improved procedural success and expanded the patient pool eligible for THV procedures. In August 2024, Boston Scientific announced that its ACURATE Prime Aortic Valve System has received CE mark approval. This state-of-the-art transcatheter aortic valve replacement system features a new valve size to serve patients with larger anatomies and is indicated for individuals at low, intermediate, and high risk experiencing severe aortic stenosis. The system features a self-expanding design and a refined deployment mechanism, enhancing the accuracy of valve positioning to improve overall patient outcomes.

Global Transcatheter Heart Valve Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global transcatheter heart valve market report based on application, technology, and region:

  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Transcatheter Aortic Valve
  • Transcatheter Pulmonary Valve
  • Transcatheter Mitral Valve
  • Technology Outlook (Revenue, USD Million, 2021 - 2033)
  • Balloon Expanded Transcatheter Valve
  • Self-Expanded Transcatheter Valve
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Application
    • 1.2.2. Technology
    • 1.2.3. Regional scope
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Application outlook
    • 2.2.2. Technology outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Transcatheter Heart Valve Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising prevalence of valvular heart diseases and aging population
      • 3.2.1.2. Increasing preference for minimally invasive cardiac procedures
      • 3.2.1.3. Technological advancements in valve design and delivery systems
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High procedural and device costs limiting accessibility
      • 3.2.2.2. Complications related to valve durability and thrombosis risk
    • 3.2.3. Market developments
      • 3.2.3.1. Key clinical trials in the transcatheter heart valve market, by region
      • 3.2.3.2. Recent product launches in the transcatheter heart valve market, by region
      • 3.2.3.3. Emerging products in the transcatheter heart valve market, by region
    • 3.2.4. Competitive factors and strategies
      • 3.2.4.1. Clinical insights
      • 3.2.4.2. Emerging technologies
      • 3.2.4.3. Market appeal
      • 3.2.4.4. Physician training and marketing
      • 3.2.4.5. Product improvements and innovations
      • 3.2.4.6. Mergers, acquisitions, and partnerships
      • 3.2.4.7. Product portfolio management
  • 3.3. Transcatheter Heart Valve Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Transcatheter Heart Valve Market: Application Estimates & Trend Analysis

  • 4.1. Definition and Scope
  • 4.2. Application Market Share Analysis, 2024 & 2033
  • 4.3. Segment Dashboard
  • 4.4. Transcatheter Aortic Valve
    • 4.4.1. Transcatheter aortic valve market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.5. Transcatheter Pulmonary Valve
    • 4.5.1. Transcatheter pulmonary valve market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.6. Transcatheter Mitral Valve
    • 4.6.1. Transcatheter mitral valve market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 5. Transcatheter Heart Valve Market: Technology Estimates & Trend Analysis

  • 5.1. Definition and Scope
  • 5.2. Application Market Share Analysis, 2024 & 2033
  • 5.3. Segment Dashboard
  • 5.4. Balloon Expanded Transcatheter Valve
    • 5.4.1. Balloon expanded transcatheter valve market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.5. Self-Expanded Transcatheter Valve
    • 5.5.1. Self-expanded transcatheter valve market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 6. Transcatheter Heart Valve Market: Regional Estimates & Trend Analysis by Application and Technology

  • 6.1. Regional Dashboard
  • 6.2. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
  • 6.3. North America
    • 6.3.1. U.S.
      • 6.3.1.1. Key country dynamics
      • 6.3.1.2. Regulatory framework/ reimbursement structure
      • 6.3.1.3. Competitive scenario
      • 6.3.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.3.2. Canada
      • 6.3.2.1. Key country dynamics
      • 6.3.2.2. Regulatory framework/ reimbursement structure
      • 6.3.2.3. Competitive scenario
      • 6.3.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.3.3. Mexico
      • 6.3.3.1. Key country dynamics
      • 6.3.3.2. Regulatory framework/ reimbursement structure
      • 6.3.3.3. Competitive scenario
      • 6.3.3.4. Mexico market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.4. Europe
    • 6.4.1. UK
      • 6.4.1.1. Key country dynamics
      • 6.4.1.2. Regulatory framework/ reimbursement structure
      • 6.4.1.3. Competitive scenario
      • 6.4.1.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.4.2. Germany
      • 6.4.2.1. Key country dynamics
      • 6.4.2.2. Regulatory framework/ reimbursement structure
      • 6.4.2.3. Competitive scenario
      • 6.4.2.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.4.3. France
      • 6.4.3.1. Key country dynamics
      • 6.4.3.2. Regulatory framework/ reimbursement structure
      • 6.4.3.3. Competitive scenario
      • 6.4.3.4. France market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.4.4. Italy
      • 6.4.4.1. Key country dynamics
      • 6.4.4.2. Regulatory framework/ reimbursement structure
      • 6.4.4.3. Competitive scenario
      • 6.4.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.4.5. Spain
      • 6.4.5.1. Key country dynamics
      • 6.4.5.2. Regulatory framework/ reimbursement structure
      • 6.4.5.3. Competitive scenario
      • 6.4.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.4.6. Norway
      • 6.4.6.1. Key country dynamics
      • 6.4.6.2. Regulatory framework/ reimbursement structure
      • 6.4.6.3. Competitive scenario
      • 6.4.6.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.4.7. Sweden
      • 6.4.7.1. Key country dynamics
      • 6.4.7.2. Regulatory framework/ reimbursement structure
      • 6.4.7.3. Competitive scenario
      • 6.4.7.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.4.8. Denmark
      • 6.4.8.1. Key country dynamics
      • 6.4.8.2. Regulatory framework/ reimbursement structure
      • 6.4.8.3. Competitive scenario
      • 6.4.8.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Japan
      • 6.5.1.1. Key country dynamics
      • 6.5.1.2. Regulatory framework/ reimbursement structure
      • 6.5.1.3. Competitive scenario
      • 6.5.1.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.5.2. China
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Regulatory framework/ reimbursement structure
      • 6.5.2.3. Competitive scenario
      • 6.5.2.4. China market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.5.3. India
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Regulatory framework/ reimbursement structure
      • 6.5.3.3. Competitive scenario
      • 6.5.3.4. India market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.5.4. Australia
      • 6.5.4.1. Key country dynamics
      • 6.5.4.2. Regulatory framework/ reimbursement structure
      • 6.5.4.3. Competitive scenario
      • 6.5.4.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.5.5. South Korea
      • 6.5.5.1. Key country dynamics
      • 6.5.5.2. Regulatory framework/ reimbursement structure
      • 6.5.5.3. Competitive scenario
      • 6.5.5.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.5.6. Thailand
      • 6.5.6.1. Key country dynamics
      • 6.5.6.2. Regulatory framework/ reimbursement structure
      • 6.5.6.3. Competitive scenario
      • 6.5.6.4. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.6. Latin America
    • 6.6.1. Brazil
      • 6.6.1.1. Key country dynamics
      • 6.6.1.2. Regulatory framework/ reimbursement structure
      • 6.6.1.3. Competitive scenario
      • 6.6.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.6.2. Argentina
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Regulatory framework/ reimbursement structure
      • 6.6.2.3. Competitive scenario
      • 6.6.2.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.7. MEA
    • 6.7.1. South Africa
      • 6.7.1.1. Key country dynamics
      • 6.7.1.2. Regulatory framework/ reimbursement structure
      • 6.7.1.3. Competitive scenario
      • 6.7.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.7.2. Saudi Arabia
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Regulatory framework/ reimbursement structure
      • 6.7.2.3. Competitive scenario
      • 6.7.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.7.3. UAE
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Regulatory framework/ reimbursement structure
      • 6.7.3.3. Competitive scenario
      • 6.7.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.7.4. Kuwait
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Regulatory framework/ reimbursement structure
      • 6.7.4.3. Competitive scenario
      • 6.7.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Company/Competition Categorization
  • 7.2. Vendor Landscape
    • 7.2.1. Key company market share analysis, 2024
    • 7.2.2. Medtronic
      • 7.2.2.1. Overview
      • 7.2.2.2. Financial Performance
      • 7.2.2.3. Product Benchmarking
      • 7.2.2.4. Strategic Initiatives
    • 7.2.3. Abbott
      • 7.2.3.1. Overview
      • 7.2.3.2. Financial Performance
      • 7.2.3.3. Product Benchmarking
      • 7.2.3.4. Strategic Initiatives
    • 7.2.4. Braile Biomedica
      • 7.2.4.1. Overview
      • 7.2.4.2. Financial Performance
      • 7.2.4.3. Product Benchmarking
      • 7.2.4.4. Strategic Initiatives
    • 7.2.5. Meril Life Sciences Pvt. Ltd., Inc.
      • 7.2.5.1. Overview
      • 7.2.5.2. Financial Performance
      • 7.2.5.3. Product Benchmarking
      • 7.2.5.4. Strategic Initiatives
    • 7.2.6. Edwards Lifesciences Corporation
      • 7.2.6.1. Overview
      • 7.2.6.2. Financial Performance
      • 7.2.6.3. Product Benchmarking
      • 7.2.6.4. Strategic Initiatives
    • 7.2.7. MicroPort Scientific Corporation
      • 7.2.7.1. Overview
      • 7.2.7.2. Financial Performance
      • 7.2.7.3. Product Benchmarking
      • 7.2.7.4. Strategic Initiatives
    • 7.2.8. Venus Medtech (Hangzhou) Inc.
      • 7.2.8.1. Overview
      • 7.2.8.2. Financial Performance
      • 7.2.8.3. Product Benchmarking
      • 7.2.8.4. Strategic Initiatives
    • 7.2.9. JenaValve
      • 7.2.9.1. Overview
      • 7.2.9.2. Financial Performance
      • 7.2.9.3. Product Benchmarking
      • 7.2.9.4. Strategic Initiatives
    • 7.2.10. Biosensors International Group, Ltd
      • 7.2.10.1. Overview
      • 7.2.10.2. Financial Performance
      • 7.2.10.3. Product Benchmarking
      • 7.2.10.4. Strategic Initiatives
    • 7.2.11. HLT Medical (Bracco)
      • 7.2.11.1. Overview
      • 7.2.11.2. Financial Performance
      • 7.2.11.3. Product Benchmarking
      • 7.2.11.4. Strategic Initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 North America transcatheter heart valve market, by region, 2021 - 2033 (USD Million)
  • Table 3 North America transcatheter heart valve market, by application, 2021 - 2033 (USD Million)
  • Table 4 North America transcatheter heart valve market, by technology, 2021 - 2033 (USD Million)
  • Table 5 U.S. transcatheter heart valve market, by application, 2021 - 2033 (USD Million)
  • Table 6 U.S. transcatheter heart valve market, by technology, 2021 - 2033 (USD Million)
  • Table 7 Canada transcatheter heart valve market, by application, 2021 - 2033 (USD Million)
  • Table 8 Canada transcatheter heart valve market, by technology, 2021 - 2033 (USD Million)
  • Table 9 Mexico transcatheter heart valve market, by application, 2021 - 2033 (USD Million)
  • Table 10 Mexico transcatheter heart valve market, by technology, 2021 - 2033 (USD Million)
  • Table 11 Europe transcatheter heart valve market, by region, 2021 - 2033 (USD Million)
  • Table 12 Europe transcatheter heart valve market, by application, 2021 - 2033 (USD Million)
  • Table 13 Europe transcatheter heart valve market, by technology, 2021 - 2033 (USD Million)
  • Table 14 Germany transcatheter heart valve market, by application, 2021 - 2033 (USD Million)
  • Table 15 Germany transcatheter heart valve market, by technology, 2021 - 2033 (USD Million)
  • Table 16 UK transcatheter heart valve market, by application, 2021 - 2033 (USD Million)
  • Table 17 UK transcatheter heart valve market, by technology, 2021 - 2033 (USD Million)
  • Table 18 France transcatheter heart valve market, by application, 2021 - 2033 (USD Million)
  • Table 19 France transcatheter heart valve market, by technology, 2021 - 2033 (USD Million)
  • Table 20 Italy transcatheter heart valve market, by application, 2021 - 2033 (USD Million)
  • Table 21 Italy transcatheter heart valve market, by technology, 2021 - 2033 (USD Million)
  • Table 22 Spain transcatheter heart valve market, by application, 2021 - 2033 (USD Million)
  • Table 23 Spain transcatheter heart valve market, by technology, 2021 - 2033 (USD Million)
  • Table 24 Denmark transcatheter heart valve market, by application, 2021 - 2033 (USD Million)
  • Table 25 Denmark transcatheter heart valve market, by technology, 2021 - 2033 (USD Million)
  • Table 26 Sweden transcatheter heart valve market, by application, 2021 - 2033 (USD Million)
  • Table 27 Sweden transcatheter heart valve market, by technology, 2021 - 2033 (USD Million)
  • Table 28 Norway transcatheter heart valve market, by application, 2021 - 2033 (USD Million)
  • Table 29 Norway transcatheter heart valve market, by technology, 2021 - 2033 (USD Million)
  • Table 30 Asia Pacific transcatheter heart valve market, by region, 2021 - 2033 (USD Million)
  • Table 31 Asia Pacific transcatheter heart valve market, by application, 2021 - 2033 (USD Million)
  • Table 32 Asia Pacific transcatheter heart valve market, by technology, 2021 - 2033 (USD Million)
  • Table 33 China transcatheter heart valve market, by application, 2021 - 2033 (USD Million)
  • Table 34 China transcatheter heart valve market, by technology, 2021 - 2033 (USD Million)
  • Table 35 Japan transcatheter heart valve market, by application, 2021 - 2033 (USD Million)
  • Table 36 Japan transcatheter heart valve market, by technology, 2021 - 2033 (USD Million)
  • Table 37 India transcatheter heart valve market, by application, 2021 - 2033 (USD Million)
  • Table 38 India transcatheter heart valve market, by technology, 2021 - 2033 (USD Million)
  • Table 39 South Korea transcatheter heart valve market, by application, 2021 - 2033 (USD Million)
  • Table 40 South Korea transcatheter heart valve market, by technology, 2021 - 2033 (USD Million)
  • Table 41 Australia transcatheter heart valve market, by application, 2021 - 2033 (USD Million)
  • Table 42 Australia transcatheter heart valve market, by technology, 2021 - 2033 (USD Million)
  • Table 43 Thailand transcatheter heart valve market, by application, 2021 - 2033 (USD Million)
  • Table 44 Thailand transcatheter heart valve market, by technology, 2021 - 2033 (USD Million)
  • Table 45 Latin America transcatheter heart valve market, by region, 2021 - 2033 (USD Million)
  • Table 46 Latin America transcatheter heart valve market, by application, 2021 - 2033 (USD Million)
  • Table 47 Latin America transcatheter heart valve market, by technology, 2021 - 2033 (USD Million)
  • Table 48 Brazil transcatheter heart valve market, by application, 2021 - 2033 (USD Million)
  • Table 49 Brazil transcatheter heart valve market, by technology, 2021 - 2033 (USD Million)
  • Table 50 Argentina transcatheter heart valve market, by application, 2021 - 2033 (USD Million)
  • Table 51 Argentina transcatheter heart valve market, by technology, 2021 - 2033 (USD Million)
  • Table 52 MEA transcatheter heart valve market, by region, 2021 - 2033 (USD Million)
  • Table 53 MEA transcatheter heart valve market, by application, 2021 - 2033 (USD Million)
  • Table 54 MEA transcatheter heart valve market, by technology, 2021 - 2033 (USD Million)
  • Table 55 South Africa transcatheter heart valve market, by application, 2021 - 2033 (USD Million)
  • Table 56 South Africa transcatheter heart valve market, by technology, 2021 - 2033 (USD Million)
  • Table 57 Saudi Arabia transcatheter heart valve market, by application, 2021 - 2033 (USD Million)
  • Table 58 Saudi Arabia transcatheter heart valve market, by technology, 2021 - 2033 (USD Million)
  • Table 59 UAE transcatheter heart valve market, by application, 2021 - 2033 (USD Million)
  • Table 60 UAE transcatheter heart valve market, by technology, 2021 - 2033 (USD Million)
  • Table 61 Kuwait transcatheter heart valve market, by application, 2021 - 2033 (USD Million)
  • Table 62 Kuwait transcatheter heart valve market, by technology, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Transcatheter heart valve market: outlook
  • Fig. 9 Transcatheter heart valve competitive insights
  • Fig. 10 Ancillary market outlook
  • Fig. 11 Transcatheter heart valve market driver impact
  • Fig. 12 Transcatheter heart valve market restraint impact
  • Fig. 13 Porter's Analysis
  • Fig. 14 PESTLE Analysis
  • Fig. 15 Transcatheter heart valve market: Application movement analysis
  • Fig. 16 Transcatheter heart valve market: Application outlook and key takeaways
  • Fig. 17 Transcatheter aortic valve market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 18 Transcatheter pulmonary valve market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 19 Transcatheter mitral valve market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 20 Transcatheter heart valve market: Technology movement analysis
  • Fig. 21 Transcatheter heart valve market: Technology outlook and key takeaways
  • Fig. 22 Balloon expanded transcatheter valve market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 23 Self-expanded transcatheter valve market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 24 Global transcatheter heart valve market: Regional movement analysis
  • Fig. 25 Global transcatheter heart valve market: Regional outlook and key takeaways
  • Fig. 26 North America, by country
  • Fig. 27 North America market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 U.S. key country dynamics
  • Fig. 29 U.S. market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 Canada key country dynamics
  • Fig. 31 Canada market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 32 Mexico key country dynamics
  • Fig. 33 Mexico market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 Europe market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 UK key country dynamics
  • Fig. 36 UK market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 Germany key country dynamics
  • Fig. 38 Germany market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 France key country dynamics
  • Fig. 40 France market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 Italy key country dynamics
  • Fig. 42 Italy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 Spain key country dynamics
  • Fig. 44 Spain market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 45 Denmark key country dynamics
  • Fig. 46 Denmark market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 47 Sweden key country dynamics
  • Fig. 48 Sweden market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 49 Norway key country dynamics
  • Fig. 50 Norway market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 51 Asia Pacific market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 52 China key country dynamics
  • Fig. 53 China market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 54 Japan key country dynamics
  • Fig. 55 Japan market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 56 India key country dynamics
  • Fig. 57 India market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 58 Thailand key country dynamics
  • Fig. 59 Thailand market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 60 South Korea key country dynamics
  • Fig. 61 South Korea market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 62 Australia key country dynamics
  • Fig. 63 Australia market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 64 Latin America market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 65 Brazil key country dynamics
  • Fig. 66 Brazil market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 67 Argentina key country dynamics
  • Fig. 68 Argentina market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 69 Middle East and Africa market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 70 South Africa key country dynamics
  • Fig. 71 South Africa market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 72 Saudi Arabia key country dynamics
  • Fig. 73 Saudi Arabia market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 74 UAE key country dynamics
  • Fig. 75 UAE market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 76 Kuwait key country dynamics
  • Fig. 77 Kuwait market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 78 Key company categorization
  • Fig. 79 Heat map analysis 2024